Pacer Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-696
Closed -$6.81K – 2695
2024
Q2
$6.81K Sell
696
-1,544
-69% -$18.8K ﹤0.01% 3607
2024
Q1
$33.8K Buy
2,240
+171
+8% +$3.1K ﹤0.01% 3321
2023
Q4
$44.6K Sell
2,069
-571
-22% -$10.5K ﹤0.01% 3149
2023
Q3
$49.1K Buy
2,640
+72
+3% +$1.68K ﹤0.01% 2477
2023
Q2
$65K Buy
2,568
+2,360
+1,135% +$59.4K ﹤0.01% 3021
2023
Q1
$5.39K Hold
208
– – ﹤0.01% 2053
2022
Q4
$4.92K Sell
208
-41
-16% -$1.1K ﹤0.01% 3199
2022
Q3
$6K Sell
249
-83
-25% -$2.91K ﹤0.01% 2047
2022
Q2
$11K Hold
332
– – ﹤0.01% 2288
2022
Q1
$24K Sell
332
-760
-70% -$54.8K ﹤0.01% 2251
2021
Q4
$100K Sell
1,092
-351
-24% -$42K ﹤0.01% 2092
2021
Q3
$183K Buy
1,443
+483
+50% +$70.3K ﹤0.01% 1332
2021
Q2
$160K Buy
960
+675
+237% +$109K ﹤0.01% 1303
2021
Q1
$52K Sell
285
-1,254
-81% -$291K ﹤0.01% 1433
2020
Q4
$308K Buy
1,539
+261
+20% +$53.1K 0.01% 1151
2020
Q3
$280K Buy
1,278
+1,214
+1,897% +$257K 0.01% 1137
2020
Q2
$12K Buy
+64
New +$11.2K ﹤0.01% 914

Other funds holding TDOC

Pacer Advisors's TDOC Position: Q3 2024 in Review

Pacer Advisors sold out of Teladoc Health (TDOC) in Q3 2024, closing a stake of 696 shares — an estimated $6.81K sold.

Pacer Advisors first reported a position in TDOC in Q2 2020 and held it in 17 quarters. The position peaked at $308K in Q4 2020. 366 funds tracked by Wall St. Rank hold TDOC as of Q3 2024.

  • Pacer Advisors reported no remaining Teladoc Health position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 696 Teladoc Health shares in Q3 2024, an estimated $6.81K.
  • Pacer Advisors first reported a position in Teladoc Health in Q2 2020 and held it in 17 quarters.
  • Pacer Advisors's Teladoc Health position peaked at $308K in Q4 2020.
  • 366 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.